<HashMap><database>biostudies-literature</database><scores/><additional><submitter>Ballaben AS</submitter><funding>Conselho Nacional de Desenvolvimento Científico e Tecnológico</funding><funding>NIAID NIH HHS</funding><funding>Coordenação de Aperfeiçoamento de Pessoal de Nível Superior</funding><funding>Fundação de Amparo à Pesquisa do Estado de São Paulo</funding><funding>National Institutes of Health</funding><pagination>104658</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC10966726</full_dataset_link><repository>biostudies-literature</repository><omics_type>Unknown</omics_type><volume>87</volume><pubmed_abstract>IMP-1-producing Pseudomonas aeruginosa was first reported in Japan and since then, bacteria with this metallo-β-lactamase have been detected worldwide. Pseudomonas monteilii (part of P. putida group) were considered an environmental pathogen with low virulence potential; however, multidrug-resistant and carbapenem-resistant P. monteilii have emerged. The present study reports the draft sequence of an extensively drug-resistant IMP-16-producing P. monteilii 597/14 isolated from cerebrospinal fluid in 2014. The sequencing data revealed bla&lt;sub>IMP-16&lt;/sub> as a gene cassette on class 1 integron, In1738 characterized in this study. Furthermore, the resistome of Pm597/14 consisted of 7 resistance genes (aadA1b, strA, strB, aacA4, bla&lt;sub>IMP-16&lt;/sub>, bla&lt;sub>OXA-2&lt;/sub>, sul1) and diverse virulence determinants involved in the adherence, LPS, antiphagocytosis, iron uptake and mercuric resistance. Although different virulence determinants were found in this study, using Galleria mellonella infection model, Pm597/14 did not kill any larvae between 7 days post-infection. P. monteilii isolates have been reported from clinical and environmental sources, carrying different MBL genes showing its potential role as their reservoir.</pubmed_abstract><journal>Infection, genetics and evolution : journal of molecular epidemiology and evolutionary genetics in infectious diseases</journal><pubmed_title>Extensively drug-resistant IMP-16-producing Pseudomonas monteilii isolated from cerebrospinal fluid.</pubmed_title><pmcid>PMC10966726</pmcid><funding_grant_id>R21AI135522</funding_grant_id><funding_grant_id>2015/23484–9</funding_grant_id><funding_grant_id>R01 AI104895</funding_grant_id><funding_grant_id>R01AI104895</funding_grant_id><funding_grant_id>2015/11728–0</funding_grant_id><funding_grant_id>2014/14494–8</funding_grant_id><funding_grant_id>R21 AI135522</funding_grant_id><pubmed_authors>Ferreira JC</pubmed_authors><pubmed_authors>Andrade LN</pubmed_authors><pubmed_authors>de Oliveira Garcia D</pubmed_authors><pubmed_authors>Doi Y</pubmed_authors><pubmed_authors>Darini ALC</pubmed_authors><pubmed_authors>Galetti R</pubmed_authors><pubmed_authors>Ballaben AS</pubmed_authors></additional><is_claimable>false</is_claimable><name>Extensively drug-resistant IMP-16-producing Pseudomonas monteilii isolated from cerebrospinal fluid.</name><description>IMP-1-producing Pseudomonas aeruginosa was first reported in Japan and since then, bacteria with this metallo-β-lactamase have been detected worldwide. Pseudomonas monteilii (part of P. putida group) were considered an environmental pathogen with low virulence potential; however, multidrug-resistant and carbapenem-resistant P. monteilii have emerged. The present study reports the draft sequence of an extensively drug-resistant IMP-16-producing P. monteilii 597/14 isolated from cerebrospinal fluid in 2014. The sequencing data revealed bla&lt;sub>IMP-16&lt;/sub> as a gene cassette on class 1 integron, In1738 characterized in this study. Furthermore, the resistome of Pm597/14 consisted of 7 resistance genes (aadA1b, strA, strB, aacA4, bla&lt;sub>IMP-16&lt;/sub>, bla&lt;sub>OXA-2&lt;/sub>, sul1) and diverse virulence determinants involved in the adherence, LPS, antiphagocytosis, iron uptake and mercuric resistance. Although different virulence determinants were found in this study, using Galleria mellonella infection model, Pm597/14 did not kill any larvae between 7 days post-infection. P. monteilii isolates have been reported from clinical and environmental sources, carrying different MBL genes showing its potential role as their reservoir.</description><dates><release>2021-01-01T00:00:00Z</release><publication>2021 Jan</publication><modification>2025-04-21T21:30:24.497Z</modification><creation>2025-04-05T18:22:17.345Z</creation></dates><accession>S-EPMC10966726</accession><cross_references><pubmed>33271337</pubmed><doi>10.1016/j.meegid.2020.104658</doi></cross_references></HashMap>